Global enterprises Block and GlaxoSmithKline (GSK) are exploring AI agent proof of concepts in financial services and drug discovery.
Enterprise leaders say recipe for AI agents is matching them to existing processes — not the other way around
Global enterprises Block and GlaxoSmithKline (GSK) are exploring AI agent proof of concepts in financial services and drug discovery.
